Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis
NCT00095498 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 227
Last updated 2021-10-25
Summary
This study will determine the efficacy, safety, and tolerability of denosumab (AMG 162) in the treatment of Rheumatoid Arthritis (RA).
Conditions
Interventions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-08-11
- Primary Completion
- 2007-04-01
- Completion
- 2007-04-01
More Related Trials
-
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
NCT01960855 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AMG 827 in Subjects With RA
NCT01059448 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis
NCT00281294 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
NCT00299546 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
NCT01764997 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
NCT00649545 ·Status: APPROVED_FOR_MARKETING
-
A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)
NCT01893255 ·Status: WITHDRAWN
-
Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate
NCT00950989 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis
NCT02499315 ·Status: TERMINATED ·Phase: PHASE1
-
INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs
NCT00902486 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
NCT07100938 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients
NCT03254966 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis
NCT00814307 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)
NCT00542022 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis
NCT00853385 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis
NCT00413660 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
NCT07171983 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
NCT00298272 ·Status: TERMINATED ·Phase: PHASE2
-
A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis
NCT00424294 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)
NCT00106535 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects
NCT02211469 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis
NCT00458146 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate
NCT00847613 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease
NCT04004429 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis
NCT00771030 ·Status: COMPLETED ·Phase: PHASE1/PHASE2